As the global patent of its tuberculosis drug comes to an end, an American pharmaceutical giant intends to ensure that generic versions will supply low- and middle-income countries.
Pakistani authorities are pulling all the stops to get rid of tuberculosis on its territory by training staff, adopting new technologies, and fighting stigmatization.
